Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Thyroid Neoplasms 1Stress Disorders, Post-Traumatic 1Neoplasms 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Eye Movement Desensitization Reprocessing × Head & Neck × Clear all
NCT07447089 2026-03-04

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

Università Cattolica di Milano

Phase NA Recruiting
25 enrolled
Head & Neck

Neoplasms, Stress Disorders, Post-Traumatic, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡